Share ownership Bonesupport Holding AB

BONEX

SE0009858152

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 10/03/2026 pm IST			5-day change	1st Jan Change
200.60 ^SEK	+3.67%		+3.40%	+6.70%

09/03	Lancelot Sverige dipped 1.4 percent in February – lagged behind strong large-cap market	FW
27/02	Bonesupport Publishes Pilot Study on Cerament G Experience in Trauma Care	FW

Share class: Bonesupport Holding AB

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	9,05,155	0	0	82.77 %
Stock B	1	6,58,05,195	5,52,16,186 ( 83.91 %)	0

Major shareholders: Bonesupport Holding AB

Name	Equities	%	Valuation
Kjell Erik Torne Selin 9.186 %	60,50,000	9.186 %	136 M kr
SEB Funds AB 4.966 %	32,70,394	4.966 %	73 M kr
HealthCap AB 4.042 %	26,61,767	4.042 %	60 M kr
SEB Investment Management AB (Denmark) 2.924 %	19,25,652	2.924 %	43 M kr
Carnegie Fonder AB 1.286 %	8,46,790	1.286 %	19 M kr
Indecap Fonder AB 0.8387 %	5,52,337	0.8387 %	12 M kr
Nordea Investment Management AB 0.7986 %	5,25,980	0.7986 %	12 M kr
Cliens Kapitalförvaltning AB 0.6681 %	4,40,000	0.6681 %	10 M kr
Storebrand Asset Management AS 0.5875 %	3,86,955	0.5875 %	9 M kr
Emil Billbäck 0.5548 %	3,65,369	0.5548 %	8 M kr
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
BONESUPPORT HOLDING AB 55.11 %	9,05,155	55.11 %	20 M kr

Breakdown by shareholder type

Institutional	18.85%
Individuals	10.48%
BONESUPPORT HOLDING AB	1.37%
Unknown	69.3%

Based on 1000 largest holdings

Geographical origin of shareholders

Sweden	15.08%
Individuals	10.48%
Denmark	3.25%
Norway	0.59%
United Kingdom	0.41%
Finland	0.22%
United States	0.18%
Germany	0.14%
Spain	0.13%
France	0.12%
Switzerland	0.05%
Belgium	0.03%
Liechtenstein	0.02%
Ireland	0.01%

Based on 1000 largest holdings

Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.

Employees

148

Sector

Pharmaceuticals

Calendar

22/04 - Earnings release - Q1 2026

More about the company